US STOCKS-Wall St reverses course to trade lower as health stocks drag

lunes 27 de abril de 2015 12:59 GYT

* Apple shares up ahead of results

* Amgen's fall drags downs biotech stocks

* Celladon nosedives on lead drug's trial failure

* Indexes down: Dow 0.2 pct, S&P 0.3 pct, Nasdaq 0.4 pct (Updates to early afternoon)

By Tanya Agrawal

April 27 (Reuters) - U.S. stocks reversed course to move lower in early afternoon trading on Monday as healthcare stocks led by Amgen dragged on the three major indexes.

The S&P Healthcare index was down 1.32 percent, with Amgen's 3 percent drop to $163.02 the biggest drag on both the S&P 500 and the Nasdaq.

The Nasdaq Biotech index was down 3.5 percent as Celladon plunged about 81 percent to a record low of $2.62.

U.S. Food and Drug Administration staff reviewers said Amgen's skin cancer immunotherapy cannot be considered for an accelerated review at this time, citing concerns over the design and results of a key study.   Continuación...